Universe · entity

Krensavage Asset Management, LLC

Institutional manager (13F) · CIK 1609251
13F holdings · as of 2026-03-31 · top 20 · reported portfolio $256k
#IssuerValueShares
1UNITED THERAPEUTICS CORP$50k84,282
2ENANTA PHARMACEUTICALS INC$36k2,866,138
3JAZZ PHARMACEUTICALS PLC$32k167,816
4BIOMARIN PHARMACEUTICAL INC$30k524,786
5EXELIXIS INC$18k415,693
6SANOFI-ADR$16k323,946
7SUPERNUS PHARMACEUTICALS INC$15k280,681
8INDIVIOR PHARMACEUTICALS INC$10k339,532
9ULTRAGENYX PHARMACEUTICAL IN$8k390,879
10VANDA PHARMACEUTICALS INC$8k1,180,388
11EMBECTA CORP$7k735,340
12GSK PLC-SPON ADR$5k96,729
13BIONTECH SE-ADR$5k59,523
14ALKERMES PLC$4k107,822
15BIOGEN INC$4k20,000
16REGENERON PHARMACEUTICALS$3k4,000
17ARDELYX INC$3k500,000
18INMODE LTD$2k120,942
19EVOLUS INC$649157,985
20ABBOTT LABORATORIES$5135,000
All filings on EDGAR ↗

Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.